Based on our proprietary chitosan matrix, MTI-12 is the first Monophasic Tissular Inductor technology with the power to regenerate neo-tissues and collagen. This technology aims to change the way doctors repair soft tissue damage resulting from aging, congenital defects, or traumatic injury.

MTI-12 is currently undergoing clinical trial investigation.